CORONARY ARTERY DISEASE, cilt.15, sa.5, ss.265-268, 2004 (SCI-Expanded)
Objectives We aimed to investigate plasma levels of molecular markers for platelet activity, thrombin activation and fibrinolytic status in patients with dilated cardiomyopathy (DCM) with and without left ventricular (LV) thrombus and to compare these markers between patients with DCM and control participants.